Edition:
United States

Ophthotech Corp (OPHT.OQ)

OPHT.OQ on NASDAQ Stock Exchange Global Select Market

64.24USD
29 Jul 2016
Change (% chg)

$-0.79 (-1.21%)
Prev Close
$65.03
Open
$64.94
Day's High
$64.94
Day's Low
$63.40
Volume
236,396
Avg. Vol
177,245
52-wk High
$80.00
52-wk Low
$35.74

OPHT.OQ

Chart for OPHT.OQ

About

Ophthotech Corporation is a biopharmaceutical company. The Company specializes in the development of therapeutics to treat diseases of the back of the eye, with a focus on developing therapeutics for age-related macular degeneration (AMD). Its advanced product candidate is Fovista, which is for use in combination with anti-vascu... (more)

Overall

Beta: --
Market Cap(Mil.): $2,272.21
Shares Outstanding(Mil.): 35.37
Dividend: --
Yield (%): --

Financials

  OPHT.OQ Industry Sector
P/E (TTM): -- 41.55 39.69
EPS (TTM): -4.27 -- --
ROI: -35.27 -9.57 14.44
ROE: -169.64 -9.91 15.49

BRIEF-Ophthotech Q1 loss per share $1.03

* Ophthotech reports first quarter 2016 financial and operating results

May 04 2016

Competitors

  Price Chg
Allergan, Inc. (AGN.N) $252.95 -2.61
Regeneron Pharmaceuticals Inc (REGN.OQ) $425.12 +14.08

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Wright Reports
$75.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.